Filing Details
- Accession Number:
- 0001209191-14-034373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-15 19:39:38
- Reporting Period:
- 2014-05-15
- Filing Date:
- 2014-05-15
- Accepted Time:
- 2014-05-15 19:39:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1516479 | Insys Therapeutics Inc. | INSY | Pharmaceutical Preparations (2834) | 510327886 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1124179 | J Steven Meyer | C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-15 | 5,000 | $21.38 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.309 to $21.393,inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.